ArticleBMC cancer2023

CRISPR-Cas9 identifies growth-related subtypes of glioblastoma with therapeutical significance through cell line knockdown.

Nannan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.